Table 1.
Previous series of liver metastases in pathological livers
Country | Cases (n) | LM in NL (%) | LM in PL (%) | P-value | Liver disease | |
---|---|---|---|---|---|---|
Hamaya et al.7 | Japan | 240,377 | 43.20 | 26.30 | >0.05 | Cirrohosis |
Vanbockrijck8 | Belgium | 2162 | 46.40 | 33.30 | <0.01 | Cirrohosis |
Hayashi et al.9 | Japan | 839 | 16.02 | 1.65 | <0.01 | Fatty liver |
Ustunomiya et al. (1999)13 | Japan | 438 | 21.20 | 8.10 | >0.05 | Infection HBV/HCV |
Song et al.10 | China | 512 | 27.10 | 13.50 | <0.05 | Infection HBV |
Lascone et al. (2005)15 | Belgium | 747 | 32.00 | 4.70 | <0.05 | Cirrhosis |
Qian et al.12 | China | 2352 | 23.47 | 7.86 | <0.01 | Hepatitis+cirrosis |
Qiu et al.11 | China | 1298 | 28.16 | 14.16 | <0.01 | Hepatitis infection |
Wang et al.17 | China | 354 | 16.90 | 2.6 | <0.01 | Hepatitis infection |
Zeng et al.18 | China | 2868 | 18.64 | 8.85 | <0.01 | Hepatitis infection |
Murono et al.16 | Japan | 604 | 9.61 | 3.17 | >0.05 | Fatty liver |
LM liver metastasis, NL normal liver, PL pathological liver, HBV hepatitis B virus, HCV hepatitis C virus